Navigation Links
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Date:7/16/2008

SCHAUMBURG, Ill., July 16 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched both ceftriaxone for injection, USP, and cefuroxime for injection, USP, two broad spectrum antibiotics for parenteral administration used to treat bacterial infections. Sagent's ceftriaxone for injection will be available to the U.S. market in 250 mg and 500 mg single dose vials, as well as 1g and 2g single dose vials; cefuroxime for injection will be available in 750 mg and 1.5g single dose vials and in 7.5g pharmacy bulk package vials. According to IMS data, combined 2007 sales for the two antibiotics were $156 million.

"We are excited to introduce these two broad-spectrum antibiotics, incorporating important features unique to Sagent, including enhanced labeling designed to enable rapid and accurate product identification," said Jeffrey M. Yordon, Sagent's chief executive officer, founder, and chairman of the board. "Importantly, this marks our fifth and sixth product launches in the past eight months, in line with our objective of rapidly introducing safe, high- quality products from our pipeline of over 200 products. Sagent is committed to bringing injectables excellence to healthcare providers and patients."

About Ceftriaxone

Ceftriaxone for injection, USP, is a broad spectrum cephalosporin antibiotic used to treat a variety of infections and is the generic equivalent of Roche's Rocephin(R) (ceftriaxone for injection). Ceftriaxone for injection, USP, is indicated for infections of the lower respiratory tract, urinary tract, skin and skin-structure, intra-abdomen, and bones and joints, as well as acute otitis media, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia and meningitis. Ceftriaxone may also reduce the incidence of postoperative infections is used as a surgical prophylaxis preoperatively.

The most common adverse effects may include nau
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
2. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
4. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The Board of Directors of BD ... declared a quarterly dividend of 54.5 cents per common share ... September 9, 2014. The indicated annual dividend rate is $2.18 ... is a leading medical technology company that partners with customers ... and evolving health needs. Our innovative solutions are focused on ...
(Date:7/22/2014)... Even within a phylum so full of mean little ... arthropods for its cruelty -- at least to crickets. Native ... is a most predatory sort of parasite. It swoops onto ... of larvae, and leaves its wicked brood to invade, kill ... of this would be possible without the fly,s ability to ...
(Date:7/22/2014)... Researchers from the National Institute of Standards and ... have demonstrated a new design for an atomic ... comb, or a microcomb. , The microcomb clock, ... of the new journal Optica ,* is ... microcomb, and its accurate conversion of optical frequencies ...
(Date:7/22/2014)... metal nanoparticles in water with ultrasound and they,ll spin ... No one yet knows exactly. But researchers at the ... their speedand it,s fast. At up to 150,000 revolutions ... any nanoscale object submerged in liquid ever reported. , ... the possibility that they could be used not only ...
Breaking Biology Technology:Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4'Comb on a chip' powers new NIST/Caltech atomic clock design 2NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... 4 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC Bulletin ... leading plasma-based pharmaceutical companies in the,People,s Republic of ... it,s common stock was approved for quotation on ... Financial Industry,Regulatory Authority (FINRA)., "We are pleased ...
... 4 ,Cord Blood America, Inc. (OTC Bulletin Board: ... ( http://www.cordblood-america.com ),focused on bringing the life ... internationally, today announced its wholly owned,subsidiary, RainMakers International, ... at the Sunday, March 2, NASCAR UAW-Dodge 400 ...
... Continues to Draw Accolades from ... Cedars-Sinai Medical Community, LOS ... its sixth anniversary this month and announced,that it has 60 ... researchers at Cedars-Sinai Medical Center. These,researchers are active in areas ...
Cached Biology Technology:China Biologic Products Commences Trading on OTC Bulletin Board 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 3Winnick Family Clinical Research Center Celebrates 6th Anniversary 2
(Date:7/22/2014)... still images and video of artistic merit created ... images were chosen from more than 250 submissions ... representing more than 25 different University departments. Twelve ... , Zach Donnell, a graduate student in molecular ... that the exhibit highlights the interplay between art ...
(Date:7/22/2014)... 2014 Aware, Inc. (NASDAQ: AWRE ), ... financial results for its second quarter ended June 30, 2014. ... $6.8 million, an increase of 53% compared to $4.4 million ... related income in the second quarter of 2014 was $1.4 ... 2013. The increase in revenue and operating income was driven ...
(Date:7/22/2014)... computer science and engineering professor with an expertise in ... Science Foundation grant worth more than $600,000 to develop ... fly., Heng Huang, an associate professor, will lead the ... Arlington Computer Science and Engineering department. Scientists are compiling ... large number of genes involved in fruit fly development ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... crop that plays a key role in sustaining food security ... of the world, particularly drought-prone regions, it plays a central ... of people in Africa and Asia. To meet the ... desirable traits, such as higher yield and quality, disease resistance, ...
... to treat nausea and motion sickness, has the potential for new ... according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist. ... drug has many potential new applications," Gohil said. "And now that ... to explore ways of using it to treat other diseases. We ...
... Boston University School of Medicine (BUSM) suggests that epigenetics may ... relapse of cancer. The findings are published online in Volume ... The term epigenetics refers to the external modifications ... do not change the DNA sequence, but instead, they affect ...
Cached Biology News:2 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 22 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 32 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 42 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 52 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 6Old drug may teach new tricks in treating infectious diseases, cancer 2Old drug may teach new tricks in treating infectious diseases, cancer 3BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy 2
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
RNase-Free DNase 50 l...
supplied with 10x reaction buffer...
Biology Products: